Proteomic Analysis of the Molecular Mechanism of Lovastatin Inhibiting the Growth of Nasopharyngeal Carcinoma Cells

Metabolic abnormalities are one of the essential features of tumors. Increasingly more studies have shown that lovastatin, a lipid-reducing drug, has visible inhibitory effects on tumors, but it has not been reported in nasopharyngeal carcinoma. In this paper, we explored the effects of lovastatin o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Yongzhen, Wang, Yumin, Xiong, Fang, Ge, Xiaolu, Li, Zheng, Li, Xiayu, Li, Yong, Li, Xiaoling, Xiong, Wei, Li, Guiyuan, Zeng, Zhaoyang, Guo, Can
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584415/
https://www.ncbi.nlm.nih.gov/pubmed/31258737
http://dx.doi.org/10.7150/jca.30454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584415/
https://www.ncbi.nlm.nih.gov/pubmed/31258737
http://dx.doi.org/10.7150/jca.30454

Ejemplares similares